Boussaad, I., Obermaier, C.D., Hanss, Z., Bobbili, D.R., Bolognin, S., Glaab, E., Wołyńska, K., Weisschuh, N., De Conti, L., May, C., Giesert, F., Grossmann, D., Lambert, A., Kirchen, S., Biryukov, M., Burbulla, L.F., Massart, F., Bohler, J., Cruciani, G., Schmid, B., Kurz-Drexler, A., May, P., Duga, S., Klein, C., Schwamborn, J.C., Marcus, K., Woitalla, D., Vogt Weisenhorn, D.M., Wurst, W., Baralle, M., Krainc, D., Gasser, T., Wissinger, B., Krüger, R., A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson's disease. Sci. Transl. Med., 12(560), 2020.
Jarazo, J., Qing, X., Schwamborn, J.C., Guidelines for fluorescent guided biallelic HDR targeting selection with PiggyBac system removal for gene editing. Front. Genet. 10 (2019), 1–12.
Larsen, S.B., et al. Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p. D620N mutation in VPS35. Stem Cell Res., 45, 2020, 101776.
Mencke, P., Boussaad, I., Önal, G., Kievit, A.J.A., Boon, A.J.W., Mandemakers, W., Bonifati, V., Krüger, R., Generation and characterization of a genetic Parkinson‘s disease-patient derived iPSC line DJ-1-delP (LCSBi008-A). Stem Cell Res., 62, 2022, 102792.
Ramsey, C.P., Giasson, B.I., L10p and P158DEL DJ-1 mutations cause protein instability, aggregation, and dimerization impairments. J. Neurosci. Res. 88 (2010), 3111–3124.
